{"slideshow_credits": null, "snippet": "The unsolicited offer of $82 a share would scuttle Mylan&#8217;s proposed acquisition of Perrigo in a shake-up of the generic drug industry.", "abstract": "Israeli generic drug manufacturer Teva makes unsolicited $40 billion offer for Dutch rival Mylan, whose $29 billion bid to acquire Irish drug maker Perrigo is rejected hours later; feverish deal-making comes amid frenzied consolidation that is reshaping the global pharmaceutical industry.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://www.nytimes.com/2015/04/22/business/dealbook/teva-offers-to-acquire-mylan-for-40-billion.html", "lead_paragraph": "The unsolicited offer of $82 a share would scuttle Mylan&#8217;s proposed acquisition of Perrigo in a shake-up of the generic drug industry.", "headline": {"main": "Teva, Maker of Generic Drugs, Bids $40 Billion to Acquire Its Rival Mylan", "print_headline": "Teva Bids $40 Billion to Acquire a Rival"}, "_id": "553652ce38f0d821acced005", "word_count": "1045", "multimedia": [{"height": 126, "url": "images/2015/04/22/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/04/22/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 399, "url": "images/2015/04/22/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/04/22/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "399"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/04/22/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/04/22/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-04-22T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Mylan Inc", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Perrigo Company", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}